Paula De Dios Andres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Paula De Dios Andres has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Brigitte Städler
Interdisciplinary Nanoscience Center (iNANO) Aarhus University Aarhus Denmark
13 shared publications - Isabella Nymann Westensee
Interdisciplinary Nanoscience Center (iNANO) Aarhus University Aarhus Denmark
5 shared publications - Edit Brodszkij
Interdisciplinary Nanoscience Center (iNANO) Aarhus University Aarhus Denmark
3 shared publications - Miguel Alexandre Ramos Docampo
Interdisciplinary Nanoscience Center (iNANO) Aarhus University Aarhus Denmark
3 shared publications Cathrine Abild Meyer
Interdisciplinary Nanoscience Center (iNANO) Aarhus University Aarhus 8000 Denmark
2 shared publicationsCecilie Ryberg
Interdisciplinary Nanoscience Center (iNANO) Aarhus University Aarhus 8000 Denmark
2 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (21)
Expression of Human CYP2D6 in Artificial Cells Based on Polymer‐Lipid Hybrid Vesicles
Artificial cells with the ability to express functional, biomedically relevant enzymes have long been a goal in the field of bottom‐up synthetic biology. Here, we demonstrate the expression of human cytochrome P450 2D6 (CYP2D6) within the lumen of giant hybrid vesicle‐based artificial cells using a cell‐free protein expression system based on the protozoan Leishmania tarentolae . The vesicle membranes comprise 1,2‐dioleoyl‐ sn ‐glycero‐3‐phosphocholine and amphiphilic block copolymers containing poly(cholesteryl methacrylate‐ co ‐butyl methacrylate) with either poly(galactose methacrylate) (pGalacMA) or poly(carboxyethyl acrylate) as the hydrophilic block. The amount and composition of the block copolymer incorporated into the giant hybrid vesicle membrane altered the artificial cells’ ability to support functional protein expression, likely through changes in membrane properties. In particular, giant hybrid vesicles containing pGalacMA supported production of enzymatically active CYP2D6. Overall, the reported approach advances the development of artificial cells capable of producing functional, biomedically relevant enzymes. Further, the effort highlights complex interplay between polymer properties and performance of biological components in the functional complexity achievable in polymer‐lipid hybrid vesicles.
- 30 October 2026
- Published by Wiley in ChemBioChem
- Vol. 27 (21)
Open AccessExpression of Human CYP2D6 in Artificial Cells Based on Polymer‐Lipid Hybrid Vesicles
Artificial cells with the ability to express functional, biomedically relevant enzymes have long been a goal in the field of bottom‐up synthetic biology. Here, we demonstrate the expression of human cytochrome P450 2D6 (CYP2D6) within the lumen of giant hybrid vesicle‐based artificial cells using a cell‐free protein expression system based on the protozoan Leishmania tarentolae . The vesicle membranes comprise 1,2‐dioleoyl‐ sn ‐glycero‐3‐phosphocholine and amphiphilic block copolymers containing poly(cholesteryl methacrylate‐ co ‐butyl methacrylate) with either poly(galactose methacrylate) (pGalacMA) or poly(carboxyethyl acrylate) as the hydrophilic block. The amount and composition of the block copolymer incorporated into the giant hybrid vesicle membrane altered the artificial cells’ ability to support functional protein expression, likely through changes in membrane properties. In particular, giant hybrid vesicles containing pGalacMA supported production of enzymatically active CYP2D6. Overall, the reported approach advances the development of artificial cells capable of producing functional, biomedically relevant enzymes. Further, the effort highlights complex interplay between polymer properties and performance of biological components in the functional complexity achievable in polymer‐lipid hybrid vesicles.
- Open Access
- 26 March 2026
- Published by Wiley in ChemSystemsChem
- Vol. 8 (3)
Transmembrane Condensation in Albumin‐Loaded Giant Vesicles Induced by an Intrinsically Disordered Protein
The interplay between biomolecular condensates and cellular membranes is central to understanding dynamic intracellular organization and membrane repair. Here, we present a minimal synthetic system to examine how membrane composition and curvature govern condensate–membrane interactions within this model platform. We demonstrate that the exposure of either lipid or polymer–lipid hybrid giant vesicles with encapsulated bovine serum albumin to a resilin‐inspired intrinsically disordered protein (IDP), which undergoes liquid–liquid phase separation, results in in situ formation of transmembrane condensates. This observation of cargo‐triggered condensation across giant vesicle membranes directly links encapsulated protein crowding to condensate nucleation and insertion. The condensation morphology was tunable by vesicle size and membrane elasticity where smaller vesicles and stiffer hybrid membranes favored transmembrane condensation, whereas larger or softer membranes promoted membrane wetting and deformation. Condensate formation locally reorganized lipids and facilitated leaflet coupling without compromising overall membrane integrity or cargo retention. This mechanistic understanding offers a unique opportunity to gain insight into the complex cell biological process of membrane repair using a minimal system.
- 26 March 2026
- Published by Wiley in ChemSystemsChem
- Vol. 8 (3)
Open AccessTransmembrane Condensation in Albumin‐Loaded Giant Vesicles Induced by an Intrinsically Disordered Protein
The interplay between biomolecular condensates and cellular membranes is central to understanding dynamic intracellular organization and membrane repair. Here, we present a minimal synthetic system to examine how membrane composition and curvature govern condensate–membrane interactions within this model platform. We demonstrate that the exposure of either lipid or polymer–lipid hybrid giant vesicles with encapsulated bovine serum albumin to a resilin‐inspired intrinsically disordered protein (IDP), which undergoes liquid–liquid phase separation, results in in situ formation of transmembrane condensates. This observation of cargo‐triggered condensation across giant vesicle membranes directly links encapsulated protein crowding to condensate nucleation and insertion. The condensation morphology was tunable by vesicle size and membrane elasticity where smaller vesicles and stiffer hybrid membranes favored transmembrane condensation, whereas larger or softer membranes promoted membrane wetting and deformation. Condensate formation locally reorganized lipids and facilitated leaflet coupling without compromising overall membrane integrity or cargo retention. This mechanistic understanding offers a unique opportunity to gain insight into the complex cell biological process of membrane repair using a minimal system.
- Open Access
- 4 July 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (39) , e2504519
Flippase‐Mediated Hybrid Vesicle Division
The assembly of synthetic systems with the ability for protein‐mediated division remains a challenge in bottom‐up synthetic biology. Here, the reconstitution of an active Drs2p–Cdc50p lipid flippase in polymer lipid hybrid vesicles (HVs) made from phospholipids and 1 or 2.5 mol% amphiphilic block copolymers, with poly(carboxyethyl acrylate) or poly(6‐ O ‐methacryloyl‐ d ‐galactopyranose) as the hydrophilic extension and either cholesteryl methacrylate or butyl methacrylate or combinations thereof as the hydrophobic blocks is demonstrated. The reconstitution of Drs2p–Cdc50p in HVs flip 2‐dioleoyl‐ sn ‐glycero‐3‐phospho‐ l ‐serine (DOPS) lipids from the inner to the outer leaflet, leading to transmembrane asymmetry. Importantly, the chemical nature of the hydrophobic block in the amphiphilic block copolymers used to assemble the HVs is crucial to support changes in the spontaneous curvature of the bilayers due to translocation of DOPS lipids that results in HV constriction and division. Taken together, this effort is a step forward in imitating cell division in synthetic assemblies toward potentially bottom‐up assembled self‐replicating units.
- 4 July 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (39) , e2504519
Open AccessFlippase‐Mediated Hybrid Vesicle Division
The assembly of synthetic systems with the ability for protein‐mediated division remains a challenge in bottom‐up synthetic biology. Here, the reconstitution of an active Drs2p–Cdc50p lipid flippase in polymer lipid hybrid vesicles (HVs) made from phospholipids and 1 or 2.5 mol% amphiphilic block copolymers, with poly(carboxyethyl acrylate) or poly(6‐ O ‐methacryloyl‐ d ‐galactopyranose) as the hydrophilic extension and either cholesteryl methacrylate or butyl methacrylate or combinations thereof as the hydrophobic blocks is demonstrated. The reconstitution of Drs2p–Cdc50p in HVs flip 2‐dioleoyl‐ sn ‐glycero‐3‐phospho‐ l ‐serine (DOPS) lipids from the inner to the outer leaflet, leading to transmembrane asymmetry. Importantly, the chemical nature of the hydrophobic block in the amphiphilic block copolymers used to assemble the HVs is crucial to support changes in the spontaneous curvature of the bilayers due to translocation of DOPS lipids that results in HV constriction and division. Taken together, this effort is a step forward in imitating cell division in synthetic assemblies toward potentially bottom‐up assembled self‐replicating units.
- Open Access
- 12 March 2025
- Published by Wiley in Advanced Biology
- Vol. 9 (5) , e2400601
Distinct Network Morphologies from In Situ Polymerization of Microtubules in Giant Polymer‐Lipid Hybrid Vesicles
Creating artificial cells with a dynamic cytoskeleton, akin to those in living cells, is a major goal in bottom‐up synthetic biology. In this study, we demonstrate the in situ polymerization of microtubules encapsulated in giant polymer‐lipid hybrid vesicles (GHVs) composed of 1,2‐dioleoyl‐sn‐glycero‐3‐phosphocholine and an amphiphilic block copolymer. The block copolymer is comprised of poly(cholesteryl methacrylate‐co‐butyl methacrylate) as the hydrophobic block and either poly(6‐O‐methacryloyl‐D‐galactopyranose) or poly(carboxyethyl acrylate) as the hydrophilic extension. Depending on the concentrations of guanosine triphosphate (GTP) or its slowly hydrolyzable analog, guanosine‐5′‐[(α,β)‐methyleno]triphosphate (GMPCPP), different microtubule morphologies are observed, including encapsulated microtubule networks, spike protrusions, as well as membrane‐associated or aggregated microtubules. Overall, this work represents a step forward in mimicking the cellular cytoskeletons and uncovering the influence of membrane composition on microtubule morphologies.
- 12 March 2025
- Published by Wiley in Advanced Biology
- Vol. 9 (5) , e2400601
Open AccessDistinct Network Morphologies from In Situ Polymerization of Microtubules in Giant Polymer‐Lipid Hybrid Vesicles
Creating artificial cells with a dynamic cytoskeleton, akin to those in living cells, is a major goal in bottom‐up synthetic biology. In this study, we demonstrate the in situ polymerization of microtubules encapsulated in giant polymer‐lipid hybrid vesicles (GHVs) composed of 1,2‐dioleoyl‐sn‐glycero‐3‐phosphocholine and an amphiphilic block copolymer. The block copolymer is comprised of poly(cholesteryl methacrylate‐co‐butyl methacrylate) as the hydrophobic block and either poly(6‐O‐methacryloyl‐D‐galactopyranose) or poly(carboxyethyl acrylate) as the hydrophilic extension. Depending on the concentrations of guanosine triphosphate (GTP) or its slowly hydrolyzable analog, guanosine‐5′‐[(α,β)‐methyleno]triphosphate (GMPCPP), different microtubule morphologies are observed, including encapsulated microtubule networks, spike protrusions, as well as membrane‐associated or aggregated microtubules. Overall, this work represents a step forward in mimicking the cellular cytoskeletons and uncovering the influence of membrane composition on microtubule morphologies.
- Open Access
- 25 February 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (30)
Cell Membrane Vesicle Camouflaged Artificial Cells
The integration of artificial and mammalian cells into semi‐synthetic aggregates remains a challenge in bottom‐up synthetic biology. Here, the fabrication of cell membrane vesicles (CMV) from HepG2 cells and their use as a coating for alginate microgels to produce camouflaged artificial cells (ACs) is demonstrated. These ACs are used for the assembly of either synthetic aggregates or semi‐synthetic aggregates. In the first case, a predator‐defendant and a liver‐like synthetic aggregates are investigated, showing promising initial steps toward complex synthetic aggregates. In the other case, the camouflaged ACs show enhanced integration with HepG2 cells. The encapsulation of a reactive oxygen species (ROS) scavenger artificial enzyme in the ACs shows protection against tert‐butyl hydroperoxide in terms of HepG2 cell viability, proliferation, and mitochondrial health in semi‐synthetic aggregates. Taken together, this effort is a substantial step forward in combining mammalian cells and ACs in the same aggregate where the latter act as support units.
- 25 February 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (30)
Open AccessCell Membrane Vesicle Camouflaged Artificial Cells
The integration of artificial and mammalian cells into semi‐synthetic aggregates remains a challenge in bottom‐up synthetic biology. Here, the fabrication of cell membrane vesicles (CMV) from HepG2 cells and their use as a coating for alginate microgels to produce camouflaged artificial cells (ACs) is demonstrated. These ACs are used for the assembly of either synthetic aggregates or semi‐synthetic aggregates. In the first case, a predator‐defendant and a liver‐like synthetic aggregates are investigated, showing promising initial steps toward complex synthetic aggregates. In the other case, the camouflaged ACs show enhanced integration with HepG2 cells. The encapsulation of a reactive oxygen species (ROS) scavenger artificial enzyme in the ACs shows protection against tert‐butyl hydroperoxide in terms of HepG2 cell viability, proliferation, and mitochondrial health in semi‐synthetic aggregates. Taken together, this effort is a substantial step forward in combining mammalian cells and ACs in the same aggregate where the latter act as support units.
- Open Access
Engineered Lipids for Intracellular Reactive Oxygen Species Scavenging in Steatotic Hepatocytes
Intracellular reactive oxygen species (ROS) in steatotic cells pose a problem due to their potential to cause oxidative stress and cellular damage. Delivering engineered phospholipids to intracellular lipid droplets in steatotic hepatic cells, using the cell's inherent intracellular lipid transport mechanisms are investigated. Initially, it is shown that tail‐labeled fluorescent lipids assembled into liposomes are able to be transported to intracellular lipid droplets in steatotic HepG2 cells and HHL‐5 cells. Further, an antioxidant, an EUK salen–manganese derivative, which has superoxide dismutase‐like and catalase‐like activity, is covalently conjugated to the tail of a phospholipid and formulated as liposomes for administration. Steatotic HepG2 cells and HHL‐5 cells incubated with these antioxidant liposomes have lower intracellular ROS levels compared to untreated controls and non‐covalently formulated antioxidants. This first proof‐of‐concept study illustrates an alternative strategy to equip native organelles in mammalian cells with engineered enzyme activity.
Open AccessEngineered Lipids for Intracellular Reactive Oxygen Species Scavenging in Steatotic Hepatocytes
Intracellular reactive oxygen species (ROS) in steatotic cells pose a problem due to their potential to cause oxidative stress and cellular damage. Delivering engineered phospholipids to intracellular lipid droplets in steatotic hepatic cells, using the cell's inherent intracellular lipid transport mechanisms are investigated. Initially, it is shown that tail‐labeled fluorescent lipids assembled into liposomes are able to be transported to intracellular lipid droplets in steatotic HepG2 cells and HHL‐5 cells. Further, an antioxidant, an EUK salen–manganese derivative, which has superoxide dismutase‐like and catalase‐like activity, is covalently conjugated to the tail of a phospholipid and formulated as liposomes for administration. Steatotic HepG2 cells and HHL‐5 cells incubated with these antioxidant liposomes have lower intracellular ROS levels compared to untreated controls and non‐covalently formulated antioxidants. This first proof‐of‐concept study illustrates an alternative strategy to equip native organelles in mammalian cells with engineered enzyme activity.
- Open Access
- 1 May 2024
- Published by Wiley in Advanced Materials Technologies
- Vol. 9 (18)
From Single‐Compartment Artificial Cells to Tissue‐Like Materials
Designing and assembling artificial cells (ACs) is a core direction in bottom‐up synthetic biology. Here, the advancements in the past 3 years in engineering ACs with focus on compartmentalization and surface modifications with the aim for their integration in semi‐synthetic tissue are outlined. Compartmentalization in vesicles, coacervates and hydrogels are discussed for encapsulated catalysis or cytoskeleton formation including the use of components of mammalian cells to increase the ACs’ complexity. Following on, the surface modification of the ACs is reviewed due to its relevance when integration of ACs with mammalian cells into semi‐synthetic tissue is the goal. Finally, the interaction of ACs and mammalian cells for cellular communication or the fabrication of semi‐synthetic tissue toward therapeutic opportunities is outlined, before a short perspective is provided.
- 1 May 2024
- Published by Wiley in Advanced Materials Technologies
- Vol. 9 (18)
Open AccessFrom Single‐Compartment Artificial Cells to Tissue‐Like Materials
Designing and assembling artificial cells (ACs) is a core direction in bottom‐up synthetic biology. Here, the advancements in the past 3 years in engineering ACs with focus on compartmentalization and surface modifications with the aim for their integration in semi‐synthetic tissue are outlined. Compartmentalization in vesicles, coacervates and hydrogels are discussed for encapsulated catalysis or cytoskeleton formation including the use of components of mammalian cells to increase the ACs’ complexity. Following on, the surface modification of the ACs is reviewed due to its relevance when integration of ACs with mammalian cells into semi‐synthetic tissue is the goal. Finally, the interaction of ACs and mammalian cells for cellular communication or the fabrication of semi‐synthetic tissue toward therapeutic opportunities is outlined, before a short perspective is provided.
- Open Access
- 11 February 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13 (12) , e2303699
Artificial Cells and HepG2 Cells in 3D‐Bioprinted Arrangements
Artificial cells are engineered units with cell‐like functions for different purposes including acting as supportive elements for mammalian cells. Artificial cells with minimal liver‐like function are made of alginate and equipped with metalloporphyrins that mimic the enzyme activity of a member of the cytochrome P450 family namely CYP1A2. The artificial cells are employed to enhance the dealkylation activity within 3D bioprinted structures composed of HepG2 cells and these artificial cells. This enhancement is monitored through the conversion of resorufin ethyl ether to resorufin. HepG2 cell aggregates are 3D bioprinted using an alginate/gelatin methacryloyl ink, resulting in the successful proliferation of the HepG2 cells. The composite ink made of an alginate/gelatin liquid phase with an increasing amount of artificial cells is characterized. The CYP1A2‐like activity of artificial cells is preserved over at least 35 days, where 6 nM resorufin is produced in 8 h. Composite inks made of artificial cells and HepG2 cell aggregates in a liquid phase are used for 3D bioprinting. The HepG2 cells proliferate over 35 days, and the structure has boosted CYP1A2 activity. The integration of artificial cells and their living counterparts into larger 3D semi‐synthetic tissues is a step towards exploring bottom‐up synthetic biology in tissue engineering.
- 11 February 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13 (12) , e2303699
Open AccessArtificial Cells and HepG2 Cells in 3D‐Bioprinted Arrangements
Artificial cells are engineered units with cell‐like functions for different purposes including acting as supportive elements for mammalian cells. Artificial cells with minimal liver‐like function are made of alginate and equipped with metalloporphyrins that mimic the enzyme activity of a member of the cytochrome P450 family namely CYP1A2. The artificial cells are employed to enhance the dealkylation activity within 3D bioprinted structures composed of HepG2 cells and these artificial cells. This enhancement is monitored through the conversion of resorufin ethyl ether to resorufin. HepG2 cell aggregates are 3D bioprinted using an alginate/gelatin methacryloyl ink, resulting in the successful proliferation of the HepG2 cells. The composite ink made of an alginate/gelatin liquid phase with an increasing amount of artificial cells is characterized. The CYP1A2‐like activity of artificial cells is preserved over at least 35 days, where 6 nM resorufin is produced in 8 h. Composite inks made of artificial cells and HepG2 cell aggregates in a liquid phase are used for 3D bioprinting. The HepG2 cells proliferate over 35 days, and the structure has boosted CYP1A2 activity. The integration of artificial cells and their living counterparts into larger 3D semi‐synthetic tissues is a step towards exploring bottom‐up synthetic biology in tissue engineering.
- Open Access
- 24 March 2023
- Published by Wiley in Chemnanomat
- Vol. 9 (5)
Self‐Immolative Polymers to Initiate Locomotion in Motors
Nanomotors that use polymers to gain locomotion is an upcoming concept. Here, we made use of self‐immolative polymers (SIP), i. e., polymers that disintegrate in a domino‐like fashion, to initiate motion in 500 nm silica particles. We selected a BSA‐triggered SIP and assessed its degradation both in solution and when deposited onto the silica particles. A 1.5‐fold increase of monomer was found in the solution compared to the controls, suggesting the SIP disintegration. The locomotion of the SIP‐coated motors was shown to have an average velocity of up to ∼3 μm s−1 when incubated with BSA. These proof of concept findings illustrate an alternative polymer‐powered motor design, which benefits from modern polymer chemistry concepts.
- 24 March 2023
- Published by Wiley in Chemnanomat
- Vol. 9 (5)
Open AccessSelf‐Immolative Polymers to Initiate Locomotion in Motors
Nanomotors that use polymers to gain locomotion is an upcoming concept. Here, we made use of self‐immolative polymers (SIP), i. e., polymers that disintegrate in a domino‐like fashion, to initiate motion in 500 nm silica particles. We selected a BSA‐triggered SIP and assessed its degradation both in solution and when deposited onto the silica particles. A 1.5‐fold increase of monomer was found in the solution compared to the controls, suggesting the SIP disintegration. The locomotion of the SIP‐coated motors was shown to have an average velocity of up to ∼3 μm s−1 when incubated with BSA. These proof of concept findings illustrate an alternative polymer‐powered motor design, which benefits from modern polymer chemistry concepts.